Results

321 - 330 of 364 results for ‘standards’.

  • Whānau, Consumer and Clinician Digital Council

    http://corporat-prod.sites.silverstripe.com/corporate-information/about-us/expert-groups/whanau-consumer-and-clinician-digital-council

    ... as a GP and healthcare lead within the Taupō–Tūrangi community. In this role, she has focused on strengthening connections within the healthcare community and improving the wellness of patients, whānau and clinicians.    Natalie has special interests in developing digital standards as well as exploring innovation within primary care.  Natalie plans to use her voice to help enhance the journey of both patients and providers within the digital space. Deborah Bush Deborah Bush Role on Council:  Consumer and Whānau   Locality: Ōtautahi (Christchurch), Te Wai ...

  • 15. Mumps

    http://tewhatuora.govt.nz/for-health-professionals/clinical-guidance/immunisation-handbook/15-mumps

    ... rubella vaccines, cases that have been vaccinated are significantly less likely to experience complications from disease such as orchitis, meningitis and hospitalisation.[ 14 ] 15.4.3. Transport, storage and handling 15.4.3. Transport, storage and handling Transport according to the National Standards for Vaccine Storage and Transportation for Immunisation Providers 2017 (2nd edition) . Store at +2°C to +8°C. Do not freeze. MMR must be reconstituted only with the diluents supplied by the manufacturer. Use MMR as soon as possible after reconstitution. If storage is necessary, reconstituted ...

  • Mumps

    http://corporat-prod.sites.silverstripe.com/for-health-professionals/clinical-guidance/communicable-disease-control-manual/mumps

    Chapter reviewed and updated in January 2021. A description of changes can be found at Updates to the Communicable Disease Control Manual . Epidemiology Expand all New Zealand epidemiology New Zealand epidemiology The incidence of mumps in New Zealand has been stable in recent years. Mumps epidemics in New Zealand occurred in 1989 and 1994 while the most recent began in 2016 (mainly in Auckland region). Before the introduction of the measles–mumps–rubella (MMR) vaccine in 1990, mumps epidemics occurred every 3–5 years. Detailed epidemiological information is available on the New Zealand

  • Healthy Ageing Strategy: update

    http://corporat-prod.sites.silverstripe.com/for-health-professionals/clinical-guidance/specific-life-stage-health-information/health-of-older-people/healthy-ageing-strategy-update

    Healthy Ageing Strategy New Zealand’s Healthy Ageing Strategy was released in December 2016. It sets the strategic direction for the next 10 years for the delivery of services to people into and throughout their later years. The vision for the Strategy is that: Older people live well, age well and have a respectful end of life in age-friendly communities. The Healthy Ageing Strategy and detailed action plan were developed through extensive collaboration with the health and social sectors in New Zealand and are aligned to the World Health Organization’s Global strategy and action plan on ag

  • Creutzfeldt-Jakob Disease and other spongiform encephalopathies

    http://corporat-prod.sites.silverstripe.com/for-health-professionals/clinical-guidance/communicable-disease-control-manual/creutzfeldt-jakob-disease-and-other-spongiform-encephalopathies

    Summary of updates to the guidance Expand all 2025 2025 June  Management of others at risk restrictions - change to the blood donation criteria to align with updated national guidance from  the New Zealand Blood service. For an overview of all updates made to the Communicable Disease Control Manual, see Updates to the Communicable Disease Control Manual – Health New Zealand | Te Whatu Ora Epidemiology Expand all New Zealand Epidemiology New Zealand Epidemiology Creutzfeldt-Jakob Disease (CJD) is one of the transmissible spongiform encephalopathies that affect humans. Sporadic CJD,

  • Community Pharmacy Agreement

    http://tewhatuora.govt.nz/health-services-and-programmes/community-pharmacy/community-pharmacy-agreement

    Health New Zealand | Te Whatu Ora contracts with more than 1000 community pharmacies throughout New Zealand to provide pharmacy services to all New Zealanders. Integrated Community Pharmacy Services Agreement (ICPSA) Expand all ICPSA Variation 6 (effective 1 December 2024) ICPSA Variation 6 (effective 1 December 2024) For contract year 1 July 2024 to 30 June 2025 NAAR 2024 Variation 6 (for providers’ consideration) Generic Letter of Offer ICPSA Variation 6 [PDF, 373 KB] Generic Letter of Offer ICPSA Variation 6 [DOCX, 267 KB] Changes to the ICPSA Variation 6 [PDF, 182 KB] Changes to the ICPS

  • Data references

    http://corporat-prod.sites.silverstripe.com/for-health-professionals/data-and-statistics/nz-health-statistics/data-references

    ... describe the file formats used to send information to the Ministry for inclusion in the national collections. Data dictionaries Data dictionaries describe the information available within the national collections and promote consistency across the collections, supporting agreed protocols and standards. Appendix B: National Collections Glossary Appendix B is a glossary of terms that are used in the national collections.  Download: Appendix B: National Collections Glossary - DOCX, 54 KB Appendix B: National Collections Glossary July 2024 Download - DOCX, 54 KB Australia Refined Diagnosis ...

  • Vaccinating health worker

    http://corporat-prod.sites.silverstripe.com/health-services-and-programmes/vaccine-information/vaccine-service-delivery/vaccinating-workforce/vaccinating-health-worker

    About the role Vaccinating health workers (VHWs) are unregistered health care workers (i.e. a health care worker who does not hold a New Zealand annual practising certificate) who have completed vaccinator training and are authorised to administer vaccines under supervision.   There are two stages to the VHW role:   VHW Stage 1 can administer COVID-19 and influenza vaccines to people 12 years of age and over, and Human Papillomavirus (HPV9) and Tetanus, Diphtheria and Pertussis (whooping cough) (Tdap) to people 11 years of age and over.   VHW Stage 2 can prepare and administer a

  • Questions and answers – Planned Care services

    http://corporat-prod.sites.silverstripe.com/health-services-and-programmes/planned-care-services/questions-and-answers-planned-care-services

    1. What are Planned Care services? Planned Care encompasses medical and surgical care, traditionally known as Elective or Arranged services that are delivered in hospitals for people who do not need to be treated right away.  It also includes a range of treatments funded by DHBs that are delivered in primary and community settings. 2. What can I expect while I am in the Planned Care process? If you need publicly funded Planned Care services you can expect: to receive information about your assessment and treatment options and whether or not they will be available to you that your lev

  • 19. Respiratory syncytial virus

    http://tewhatuora.govt.nz/for-health-professionals/clinical-guidance/immunisation-handbook/19-respiratory-syncytial-virus

    ... hospitalisation due to RSV infection by 56 percent (relative risk 0.44; 95% CI 0.30-0.64), but evidence is uncertain around mortality (relative risk 0.69; 0.42-1.15).[ 27 ] 19.4.3. Transport, storage and handling 19.4.3. Transport, storage and handling Transport according to the National Standards for Vaccine Storage and Transportation for Immunisation Providers 2017 (2nd edition) (external link) . Store at +2°C to +8°C. Do not freeze. Protect from light. 19.4.4. Dosage and administration 19.4.4. Dosage and administration Adjuvanted RSVpreF vaccine, Arexvy A single 0.5 mL dose of Arex ...